• Policy
• "People do not recognize generic equivalence"…
• by Lee, Hye-Kyung Jun 18, 2024 05:48am

• Policy
• Ceprotin Inj passes reimbursement committee’s review
• by Lee, Tak-Sun Jun 18, 2024 05:48am

• Policy
• Fasenra·Xpovio reimb from July…Jardiance price cut
• by Lee, Tak-Sun Jun 18, 2024 05:47am

• Policy
• Multiple myeloma drug Elrexfio receives conditional approval
• by Lee, Hye-Kyung Jun 17, 2024 05:46am

• Policy
• External reference pricing reevaluations are nearly ready
• by Lee, Tak-Sun Jun 17, 2024 05:46am

• Policy
• CKD speeds up developing Duvie+Jardiance+metformin therapy
• by Lee, Hye-Kyung Jun 14, 2024 05:47am

• Policy
• Yuhan’s NSCLC new drug earns approval for clinical trial
• by Lee, Hye-Kyung Jun 14, 2024 05:47am

• Policy
• Drug pricing negotiations complete for Idelvion in KOR
• by Lee, Tak-Sun Jun 13, 2024 05:48am

• Policy
• "Chickenpox vaccine 'Sky Varicella Inj' is safe…"
• by Lee, Jeong-Hwan Jun 13, 2024 05:48am

• Policy
• CPAC ‘Scemblix’s orphan drug designation is valid’
• by Lee, Hye-Kyung Jun 13, 2024 05:48am